HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Repiscak Selected Research

Peter Repiscak Research Topics

Disease

7Prostatic Neoplasms (Prostate Cancer)
04/2022 - 01/2018
5Neoplasms (Cancer)
04/2022 - 01/2016
1Neoplasm Metastasis (Metastasis)
04/2022
1Polyploidy
12/2020
1Disease Resistance
11/2020
1Carcinogenesis
01/2020

Drug/Important Bio-Agent (IBA)

2AndrogensIBA
01/2022 - 11/2020
2Androgen Receptors (Androgen Receptor)IBA
01/2020 - 01/2020
2LipidsIBA
01/2020 - 01/2016
1NucleotidesIBA
04/2022
1N-acetylaspartate (N-acetyl aspartate)IBA
04/2022
1RNA (Ribonucleic Acid)IBA
04/2022
1Aspartic Acid (Aspartate)FDA Link
04/2022
1Glutamic Acid (Glutamate)FDA Link
04/2022
1Hormones (Hormone)IBA
04/2022
1SphingolipidsIBA
04/2022
1Docetaxel (Taxotere)FDA Link
12/2020
1LigandsIBA
01/2020
1Complement System Proteins (Complement)IBA
01/2020
12,4-dienoyl-CoA reductaseIBA
01/2020
1CateninsIBA
01/2020
1RNA Polymerase IIIIBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2018
1Scavenger Receptors (Scavenger Receptor)IBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2016

Therapy/Procedure

6Castration
04/2022 - 01/2018
5Therapeutics
01/2022 - 01/2016
1Drug Therapy (Chemotherapy)
12/2020